p53 expression as a prognostic determinant in resected distal bile duct carcinoma.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Surgical Oncology

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/EJSO.1998.0645PMID 10336811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholangiocarcinoma

  2010cited by this paper
• Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.

  2008cited by this paper
• Assessment of the expression of p53, MIB‐1 (Ki‐67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct

  1998cited by this paper
• Diagnostic and prognostic value of incidence of k‐ras codon 12 mutations in resected distal bile duct carcinoma

  1998cited by this paper
• The incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma: What is its diagnostic and prognostic value?

  1998cited by this paper
• P53 and induction of apoptosis as a target for anticancer therapy.

  1996cited by this paper
• Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

  1996cited by this paper
• Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

  1996cited by this paper
• New prognostic factors in resectable non-small cell lung cancer.

  1996cited by this paper
• Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region

  1995cited by this paper
• p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival

  1995cited by this paper
• p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater

  1995cited by this paper
• An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

  1994cited by this paper
• An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas

  1994cited by this paper
• Overexpression of p53 protein in adenocarcinoma of the pancreas.

  1994cited by this paper
• Cancer therapy meets p53.

  1994cited by this paper
• The p53 tumor suppressor gene.

  1994cited by this paper
• Multifactorial analysis of p53 alteration in human cancer: A review

  1994cited by this paper
• p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness.

  1994cited by this paper
• Accumulation of nuclear p53 and tumor progression in bladder cancer.

  1994cited by this paper
• Allelotype of pancreatic adenocarcinoma.

  1994cited by this paper
• Tumourigenesis associated with the p53 tumour suppressor gene.

  1993cited by this paper
• Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.

  1992cited by this paper
• p53 expression and prognosis in gastric carcinoma

  1992cited by this paper
• The p53 tumor-suppressor gene.

  1992cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition

  1992cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• Changing patterns in diagnosis and management of bile duct cancer.

  1990cited by this paper
• Suppression of human colorectal carcinoma cell growth by wild-type p53.

  1990cited by this paper
• Mutant p53—the commonest genetic abnormality in human cancer?

  1990cited by this paper
• Increased expression of mutant forms of p53 oncogene in primary lung cancer.

  1990cited by this paper
• Allelotype of colorectal carcinomas.

  1989cited by this paper
• Carcinoma

  1906cited by this paper

• The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment

  2021cites this paper
• Synchronous Gall Bladder and Bile Duct Cancer: A Short Series of Seven Cases and a Brief Review of Literature.

  2017cites this paper
• Extrahepatic Cholangiocarcinoma: Carcinoma of the Middle and Distal Common Bile Duct (Middle and Lower Bile Duct Carcinomas)

  2016cites this paper
• Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity

  2015cites this paper
• Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers.

  2015cites this paper
• Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma

  2013cites this paper
• Digestive organs: Carcinoma of the gallbladder and extrahepatic bile ducts

  2011cites this paper
• A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.

  2011cites this paper
• p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies

  2011cites this paper
• Liver transplantation for non–hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature

  2010cites this paper
• Prognostic molecular markers in cholangiocarcinoma: a systematic review.

  2009cites this paper
• Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 Cases

  2007cites this paper
• Oncogenes in tumors of gallbladder and biliary tract.

  2004cites this paper
• Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.

  2003cites this paper
• 胆管細胞癌および肝外胆管癌におけるp 53 遺伝子異常

  2001cites this paper
• Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts

  2001cites this paper
• Papillary adenocarcinoma of the subvesical duct.

  2001cites this paper
• Carcinoid Tumors of the Extrahepatic Bile Ducts: A Study of Seven Cases

  2000cites this paper
• Diagnosis and non-surgical treatment of bile duct carcinoma: developments in the past decade

  2000cites this paper